Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Export citation
Reference Manager

Cite by
Google Scholar

Article History
Submitted: 06 Oct 2012
Revised: 31 Oct 2012
First published online: 07 Feb 2013

Article Access Statistics
Abstract Page Views: 228
PDF Downloads: 141
Full Text Views: 0

Adv Pharm Bull. 2013;3(1):9-11 doi: 10.5681/apb.2013.002
PMID:24312805        PMCID:PMC3846049

New Approaches in Immunotherapy of Behçet Disease


Fatemeh Zare Shahneh, Mozhdeh Mohammadian, Zohreh Babaloo * , Behzad Baradaran

Behçet Disease (BD) is an autoimmune disorder with recurrent ocular, vascular, central nervous system, articular, mucocutaneous, and gastrointestinal manifestations with unclear etiology and pathogenesis. The further characterization of inflammatory features of Behçet’s disease may eventually lead to development of better treatment options. Clinical and laboratory observations suggested an important role of IL-17, IL-21 and neutrophil-mediated process in the pathogenesis of BD. New therapeutic modalities target specific and nonspecific suppression of the immune system. The various non-specific immunosuppressive drugs, used either alone or in combinations, frequently fail to control inflammation or maintain remissions. Due to encouraging clinical results (i.e. Antigenic specification, prolonged survival with acceptable levels of toxicity); antibody-based drugs could be effective for the clinical management of Behçet’s disease.

First name  
Last name  
Email address  
Security code

This Article

Google Scholar
Articles by Zare Shahneh F
Articles by Mohammadian M
Articles by Babaloo Z
Articles by Baradaran B

Articles by Zare Shahneh F
Articles by Mohammadian M
Articles by Babaloo Z
Articles by Baradaran B

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN